Daily Newsletter

05 February 2024

Daily Newsletter

05 February 2024

Orano Med begins construction of pharmaceutical facility in France 

The facility is intended to meet the needs of cancer patients who have limited treatment options.

Upasana Mukherjee February 05 2024

Pharmaceutical company Orano Med has commenced construction of its manufacturing facility, Alpha Therapy Laboratory (ATLab) Valenciennes, in Onnaing, France. 

The lab is said to become Europe’s first industrial-scale facility dedicated to the production of lead-212-based radioligand therapies.  

Once built, the facility will help address the production challenges of these therapies and meet the needs of cancer patients with limited treatment options. 

The ground-breaking ceremony for the facility was attended by Onnaing mayor Xavier Jouanin; Valenciennes Métropole president and Valenciennes mayor Laurent Degallaix; as well as regional councillor for the Circular Economy Aurore Colson, among others.

Targeted Alpha Therapy uses lead-212 to combine biological molecules’ targeting capabilities with the cell-killing properties of alpha emissions.  

The facility, spanning more than 3,000m², represents an investment of €29m ($31.24m). 

Orano Projects & Innovation R&D and Nuclear Medicine senior executive vice-president Guillaume Dureau said: “The ATLab in Onnaing is a very important step in our development strategy and is situated at the very heart of the industrial fabric of the Valenciennes metropolitan area and the Hauts-de-France region.  

“The expansion of our production capacity in the radiopharmaceutical field is part of a drive to revitalise our country’s industrial and economic fabric.” 

The development is expected to create 25 direct jobs and will concentrate on producing and distributing lead-212 therapies developed by Orano within Europe.

It has also been selected under the France 2030 plan and will receive public funding of approximately €3.8m to work towards this.  

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close